BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32156138)

  • 1. Assessment of ovarian reserve by serum anti-Müllerian hormone in patients with systemic lupus erythematosus: a meta-analysis.
    Luo W; Mao P; Zhang L; Chen X; Yang Z
    Ann Palliat Med; 2020 Mar; 9(2):207-215. PubMed ID: 32156138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve.
    Di Mario C; Petricca L; Gigante MR; Barini A; Barini A; Varriano V; Paglionico A; Cattani P; Ferraccioli G; Tolusso B; Gremese E
    Endocrine; 2019 Feb; 63(2):369-375. PubMed ID: 30324323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Report: The Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen Does Not Impact the Ovarian Reserve, as Measured by Serum Levels of Anti-Müllerian Hormone.
    Tamirou F; Husson SN; Gruson D; Debiève F; Lauwerys BR; Houssiau FA
    Arthritis Rheumatol; 2017 Jun; 69(6):1267-1271. PubMed ID: 28235250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus.
    Mok CC; Chan PT; To CH
    Arthritis Rheum; 2013 Jan; 65(1):206-10. PubMed ID: 23044647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients.
    Marder W; McCune WJ; Wang L; Wing JJ; Fisseha S; McConnell DS; Christman GM; Somers EC
    Gynecol Endocrinol; 2012 Aug; 28(8):624-7. PubMed ID: 22296584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone in reproductive age women with systemic lupus erythematosus.
    Velarde-Ochoa Mdel C; Esquivel-Valerio JA; Vega-Morales D; Skinner-Taylor CM; Galarza-Delgado DÁ; Garza-Elizondo MA
    Reumatol Clin; 2015; 11(2):78-82. PubMed ID: 24815955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of anti-Müllerian hormone levels in premenopausal patients with systemic lupus erythematosus.
    Gasparin AA; Souza L; Siebert M; Xavier RM; Chakr RM; Palominos PE; Brenol JC; Monticielo OA
    Lupus; 2016 Mar; 25(3):227-32. PubMed ID: 26223296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of ovarian reserve with anti-Müllerian hormone in female patients with systemic lupus erythematosus].
    Chen D; Yuan S; Zhan Z; Zhan Y; Yang X; Liang L
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):977-80. PubMed ID: 24851682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate?
    de Araujo DB; Yamakami LY; Aikawa NE; Bonfá E; Viana VS; Pasoto SG; Pereira RM; Serafin PC; Borba EF; Silva CA
    Scand J Rheumatol; 2014; 43(6):503-11. PubMed ID: 24881927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Müllerian hormone in African-American women with systemic lupus erythematosus.
    Angley M; Spencer JB; Lim SS; Howards PP
    Lupus Sci Med; 2020 Nov; 7(1):. PubMed ID: 33132225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone.
    Lawrenz B; Henes J; Henes M; Neunhoeffer E; Schmalzing M; Fehm T; Kïtter I
    Lupus; 2011 Oct; 20(11):1193-7. PubMed ID: 21768179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus.
    Martins NFE; Seixas MI; Pereira JP; Costa MM; Fonseca JE
    Clin Rheumatol; 2017 Dec; 36(12):2853-2854. PubMed ID: 28828533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide.
    Morel N; Bachelot A; Chakhtoura Z; Ghillani-Dalbin P; Amoura Z; Galicier L; Aumaitre O; Piette JC; Pourrat J; Boutin D; Sacre K; Kahn JE; Duhaut P; Farge D; Francès C; Guettrot-Imbert G; Harlé JR; Lambotte O; Le Guern V; Sène D; Trad S; Vidal E; Sarrot-Reynauld F; Gompel A; Tanguy ML; Touraine P; Lacorte JM; Costedoat-Chalumeau N;
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3785-92. PubMed ID: 23833039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-Müllerian hormone levels as a predictor of ovarian reserve in systemic lupus erythematosus patients: a review].
    Gasparin AA; Chakr RM; Brenol CV; Palominos PE; Xavier RM; Souza L; Brenol JC; Monticielo OA
    Rev Bras Reumatol; 2015; 55(4):363-7. PubMed ID: 25583001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary study on the changes of ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age.
    Gao H; Ma J; Wang X; Lv T; Liu J; Ren Y; Li Y; Zhang Y
    Lupus; 2018 Mar; 27(3):445-453. PubMed ID: 28820360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's).
    Clowse ME; Copland SC; Hsieh TC; Chow SC; Hoffman GS; Merkel PA; Spiera RF; Davis JC; McCune WJ; Ytterberg SR; St Clair EW; Allen NB; Specks U; Stone JH;
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1777-81. PubMed ID: 22127969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the Ovarian Reserve by Serum Anti-Müllerian Hormone in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis.
    Zhang XH; Zhang YA; Chen X; Qiao PY; Zhang LY
    Int Arch Allergy Immunol; 2022; 183(4):462-469. PubMed ID: 34929705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary study on anti-Müllerian hormone, antral follicle count, menstruation and lymphocyte subsets in systemic lupus erythematosus patients.
    Girbash EF; Abdelwahab SM; Fahmi DS; Abdeldayem HM; Ghonaim R; Atta DS
    Int J Gynaecol Obstet; 2022 Oct; 159(1):129-135. PubMed ID: 35064969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy.
    Ma W; Zhan Z; Liang X; Chen J; Huang X; Liao C
    J Womens Health (Larchmt); 2013 Dec; 22(12):1023-7. PubMed ID: 24283710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regular menstrual cycles do not rule out ovarian damage in adult women with systemic lupus erythematosus.
    Malheiro OB; Rezende CP; Rocha AL; Del Puerto HL; Ferreira GA; Reis FM
    Gynecol Endocrinol; 2014 Oct; 30(10):701-4. PubMed ID: 24898133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.